WRBY · Insider Trading
Warby Parker Inc.
Every open-market purchase and sale reported by WRBY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Jeffrey Jacob Raider | Director | Sell | −15,000 | −$415.50K |
| 2026-10-02 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | −4,386 | −$2.77M |
| 2026-09-04 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | +9,294 | −$278.28K |
| 2026-09-04 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | +9,294 | −$278.28K |
| 2026-08-14 | Neil Harris Blumenthal | Co-Chief Executive Officer | M | — | — |
| 2026-07-08 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$275.91K |
| 2026-07-08 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$1.62M |
| 2026-07-02 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | −28,347 | −$6.45M |
| 2026-07-02 | Jeffrey Jacob Raider | Director | Sell | −22,500 | −$668.70K |
| 2026-07-02 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | −28,475 | −$7.19M |
| 2026-07-01 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$1.09M |
| 2026-06-23 | Neil Harris Blumenthal | Co-Chief Executive Officer | M | — | — |
| 2026-06-18 | Teresa Briggs | Director | Sell | −5,000 | −$129.68K |
| 2026-06-12 | Youngme E Moon | Director | Sell | −10,000 | −$265.30K |
| 2026-06-10 | Youngme E Moon | Director | A | +9,004 | — |
| 2026-06-10 | Bradley E Singer | Director | A | +9,004 | — |
| 2026-06-10 | Jeffrey Jacob Raider | Director | A | +9,004 | — |
| 2026-06-10 | Andrew Hunt | Director | A | +12,005 | — |
| 2026-06-10 | Teresa Briggs | Director | A | +9,004 | — |
| 2026-06-10 | Ronald A Williams | Director | A | +13,006 | — |
| 2026-06-04 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | +9,294 | −$280.49K |
| 2026-06-04 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | +9,294 | −$280.49K |
| 2026-05-21 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$1.89M |
| 2026-05-15 | Bradley E Singer | Director | Sell | −25,000 | −$715.17K |
| 2026-04-20 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$2.47M |
| 2026-03-13 | Jeffrey Jacob Raider | Director | Sell | −25,000 | −$635.75K |
| 2026-03-06 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | +6,022 | −$203.91K |
| 2026-03-06 | Bradley E Singer | Director | Sell | −15,793 | −$434.78K |
| 2026-03-06 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | +6,022 | −$203.91K |
| 2026-03-04 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | +7,024 | −$235.11K |
| 2026-03-04 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | +7,024 | −$235.11K |
| 2026-02-12 | Adrian V Mitchell | Chief Financial Officer | A | −85,307 deriv. | — |
| 2026-01-15 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$19.79K |
| 2026-01-15 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$2.36M |
| 2026-01-09 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$1.35M |
| 2026-01-09 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$2.61M |
| 2026-01-06 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$1.78M |
| 2026-01-06 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$3.76M |
| 2025-12-18 | David Abraham Gilboa | Co-Chief Executive Officer | G | −50,000 deriv. | — |
| 2025-12-18 | Joel E Cutler | Director | MIXED | −19,932 | −$518.48K |
| 2025-12-15 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$6.04M |
| 2025-12-15 | Jeffrey Jacob Raider | Director | Sell | −25,000 | −$685.50K |
| 2025-12-15 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$3.03M |
| 2025-12-15 | Youngme E Moon | Director | Sell | −38,832 | −$1.13M |
| 2025-12-04 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | +4,386 | −$102.03K |
| 2025-12-04 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | +4,386 | −$102.03K |
| 2025-10-03 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$3.41M |
| 2025-09-19 | Neil Harris Blumenthal | Co-Chief Executive Officer | MIXED | — | −$245.37K |
| 2025-09-19 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$1.63M |
| 2025-09-15 | David Abraham Gilboa | Co-Chief Executive Officer | MIXED | — | −$1.13M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Jeffrey Jacob Raider | Director | 2,590,772 | $66.40M |
| Andrew Hunt | Director | 1,941,236 | $49.75M |
| Steven Clive Miller | Chief Financial Officer | 248,875 | $6.38M |
| Neil Harris Blumenthal | Co-Chief Executive Officer | 236,020 | $6.05M |
| Bradley E Singer | Director | 125,030 | $3.20M |
| Ronald A Williams | Director | 122,802 | $3.15M |
| Joel E Cutler | Director | 84,375 | $2.16M |
| Teresa Briggs | Director | 64,852 | $1.66M |
| David Abraham Gilboa | Co-Chief Executive Officer | 40,927 | $1.05M |
| Youngme E Moon | Director | 26,061 | $667.94K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the WRBY quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.